Subgrouping headache and facial pain patients by manual examination – a potential marker to predict treatment outcomes after greater occipital nerve block
- Conditions
- MigraineG43G44Other headache syndromes
- Registration Number
- DRKS00015995
- Lead Sponsor
- niversitätsklinikum Hamburg-Eppendorf
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 71
Inclusion Criteria
Adult patients with high frequency episodic or chronic migraine, cluster headache or facial pain diagnosed by a neurologist experienced in headache based on the classification of IHS III that should receive a GON-block as a clinical required intervention.
Exclusion Criteria
diagnosed pathology of the cervical spine, trauma of the cervical spine in the past, pregnancy or lactation period, pain medication in more than 10 days a month to exclude medication overuse headache, relevant internistic, psychiatric or neurologic deseases, misuse of drugs or alcohol, allergy to local anaestesic or cortisone.
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Headache frequency. Measured in pain days per 4 weeks.
- Secondary Outcome Measures
Name Time Method Migraine days per 4 weeks. Severity and duration of headache. Duration of numbness after injection in hours. Frequency, kind and dosage of acute medication. Possible side effects of the GON-Block. All measured with headache diary.<br>Level of disability due to headache measured with the Migraine Disability Index (MIDAS), due to facial pain measured with the Craniofacial Pain And Disability Inventory (CF_PDI), due to neck pain measured with the Neck Disability Index (NDI). <br>Change in sensitivity to touch (von Frey Filaments) and pressure (manual palpation). Change in allodynia via the Allodynia Symptome Checklist (ASC-12) and the Global Rating of Change (GROC).